Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Tumor cells circulating in the blood are the “germ cells” of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

A couple from a small town outside Peoria celebrated their first Christmas with their new baby after a scary cancer diagnosis ...

The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance.

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

SENTI-202 is under clinical development by Senti Biosciences and currently in Phase I for Blood Cancer. According to GlobalData, Phase I drugs for Blood Cancer have a 68% phase transition success rate ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Neuroendocrine Tumors. According to GlobalData, Phase II drugs for Neuroendocrine Tumors have a 28% phase transition ...

Researchers have discovered that a low-cost blood pressure medication may effectively treat a noncancerous but invasive brain tumor ... for the development of cancer drugs,” study lead Wu ...